Shareholding for the Period Ended December 31, 2016
Jubilant Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here19-01-2017
19-01-2017
Schedule of Investor Conference Call for Jubilant Life Sciences Limited - Unaudited Financial Results for the quarter ended December 31, 2016
Jubilant Life Sciences Ltd has informed BSE regarding "Schedule of Investor Conference Call for Jubilant Life Sciences Limited - Unaudited Financial Results for the quarter ended December 31, 2016".19-01-2017
Q3 results on Feb 07, 2017
Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 07, 2017, inter alia, to consider Unaudited Financial Results of the Company for the quarter ended December 31, 2016 (Q3).19-01-2017
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Jubilant Life Sciences Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.13-01-2017
Issuance of Commercial Papers of Rs. 50 crore
Jubilant Life Sciences Ltd has informed BSE regarding "Issuance of Commercial Papers of Rs. 50 crore".11-01-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jubilant Stock Holding Pvt Ltd09-01-2017
Issuance of Commercial Papers of Rs. 50 crore
Jubilant Life Sciences Ltd has informed BSE regarding "Issuance of Commercial Papers of Rs. 50 crore".05-01-2017
Jubilant Life shares rally on US contract
Shares of Jubilant Life Sciences today surged 12.5 per cent after the company said its subsidiary has signed long-term contracts in the US for the supply of some of its diagnostic and therapeutic...04-01-2017
Jubilant announces signing of long term contracts in Radiopharma business
Jubilant Life Sciences Ltd has submitted to BSE a copy of a communication regarding signing of contracts for Radiopharma business titled "Jubilant announces signing of long term contracts in Radiopharma business"04-01-2017
Intimation of Schedule of Investor / Analysts Meetings on January 04, 2017
Jubilant Life Sciences Ltd has informed BSE regarding "Intimation of Schedule of Investor / Analysts Meetings on January 04, 2017".03-01-2017